Psychosocial aspects of PKU: Hidden disabilities - A review

Molecular Genetics and Metabolism

Volumn 99, Issue SUPPL., 2010, Pages

  Gentile, J K ^a   Ten Hoedt, A E ^b   Bosch, A M ^b  

^a 11S Medical Intensive Care Unit   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Hidden disabilities; Neurocognitive function; Phenylketonuria; Psychosocial function

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TYROSINE;

ACADEMIC ACHIEVEMENT; AMINO ACID METABOLISM; ANXIETY; ARTICLE; COGNITIVE DEFECT; DEPRESSION; DIET RESTRICTION; DIET SUPPLEMENTATION; EMOTION; EMPLOYMENT; FATIGUE; HUMAN; HUMAN RELATION; JOB PERFORMANCE; MENTAL DISEASE; MENTAL STRESS; METABOLIC REGULATION; PERSONAL AUTONOMY; PHENYLKETONURIA; PLANNING; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RISK FACTOR; SOCIAL DISABILITY; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY;

EID: 72249119031     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.10.183     Document Type: Article

References (40)

1. Scriver C.R., Waters P.J., Sarkissian C., Ryan S., Prevost L., Côté D., Novak J., Teebi S., and Nowacki P.M. PAHdb: a locus-specific knowledgebase. Hum. Mutat. 15 (2000) 99-104
2. Moyle J.J., Fox A.M., Arthur M., Bynevelt M., and Burnett J.R. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol. Rev. 17 (2007) 91-101
3. Waisbren S.E., Brown M.J., de Sonneville L.M., and Levy H.L. Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr. Suppl. 407 (1994) 98-103
4. Simon E., Schwarz M., Roos J., Dragano N., Geraedts M., Siegrist J., Kamp G., and Wendel U. Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual. Life Outcomes 6 (2008) 25
5. Huttenlocher P.R. The neuropathology of phenylketonuria: human and animal studies. Eur. J. Pediatr. 159 Suppl. 2 (2000) S10
6. Knudsen G.M., Hasselbalch S., Toft P.B., Christensen E., Paulson O.B., and Lou H. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J. Inherit. Metab. Dis. 18 (1995) 653-664
7. Lou H.C. Dopamine precursors and brain function in phenylalanine hydroxylase deficiency. Acta Paediatr. Suppl. 407 (1994) 86-88
8. Diamond A., Prevor M.B., Callender G., and Druin D.P. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr. Soc. Res. Child Dev. 62 (1997) 1-208
9. Leuzzi V., Tosetti M., Montanaro D., Carducci C., Artiola C., Carducci C., Antonozzi I., Burroni M., Carnevale F., Chiarotti F., Popolizio T., Giannatempo G.M., D'Alesio V., and Scarabino T. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 T MRI and magnetic resonance spectroscopy (1H MRS) study. J. Inherit. Metab. Dis. 30 (2007) 209-216
10. Joseph B., and Dyer C.A. Relationship between myelin production and dopamine synthesis in the PKU mouse brain. J. Neurochem. 86 (2003) 615-626
11. Gentile J., Fickie M.R., and Waisbren S. Phenylketonuria: outcomes and treatment. Pediatr. Health 2 (2008) 225-234
12. Gassió R., Fusté E., López-Sala A., Artuch R., Vilaseca M.A., and Campistol J. School performance in early and continuously treated phenylketonuria. Pediatr. Neurol. 33 (2005) 267-271
13. Lundstedt G., Johansson A., Melin L., and Alm J. Adjustment and intelligence among children with phenylketonuria in Sweden. Acta Paediatr. 90 (2001) 1147-1152
14. Weglage J., Fünders B., Wilken B., Schubert D., Schmidt E., Burgard P., and Ullrich K. Psychological and social findings in adolescents with phenylketonuria. Eur. J. Pediatr. 151 (1992) 522-525
15. Schmidt H., Burgard P., Pietz J., and Rupp A. Intelligence and professional career in young adults treated early for phenylketonuria. Eur. J. Pediatr. 155 (1996) S97-S100
16. Waisbren S.E., Noel K., Fahrbach K., Cella C., Frame D., Dorenbaum A., and Levy H. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol. Genet. Metab. 92 (2007) 63-70
17. Burgard P. Development of intelligence in early treated phenylketonuria. Eur. J. Pediatr. 159 Suppl. 2 (2000) S74-S79
18. Anderson V.A., Anderson P., Northam E., Jacobs R., and Mikiewicz O. Relationships between cognitive and behavioral measures of executive function in children with brain disease. Child Neuropsychol. 8 (2002) 231-240
19. Channon S., Goodman G., Zlotowitz S., Mockler C., and Lee P.J. Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch. Dis. Child. 2 (2009) 213-218
20. Huijbregts S.C., de Sonneville L.M., Licht R., van Spronsen F.J., Verkerk P.H., and Sergeant J.A. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 40 (2002) 7-15
21. Huijbregts S., de Sonneville L., Licht R., Sergeant J., and van Spronsen F. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria. Dev. Neuropsychol. 22 (2002) 481-499
22. Gilotty L., Kenworthy L., Sirian L., Black D.O., and Wagner A.E. Adaptive skills and executive function in autism spectrum disorders. Child Neuropsychol. 8 (2002) 241-248
23. Kazak A.E., Reber M., and Snitzer L. Childhood chronic disease and family functioning: a study of phenylketonuria. Pediatrics 81 (1988) 224-230
24. Brissos S., Dias V.V., and Kapczinski F. Cognitive performance and quality of life in bipolar disorder. Can. J. Psychiatry 53 (2008) 517-524
25. Weglage J., Fünders B., Wilken B., Schubert D., and Ullrich K. School performance and intellectual outcome in adolescents with phenylketonuria. Acta Paediatr. 82 (1993) 582-586
26. Stemerdink B.A., Kalverboer A.F., van der Meere J.J., van der Molen M.W., Huisman J., de Jong L.W., M Slijper F., Verkerk P.H., and van Spronsen F.J. Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J. Inherit. Metab. Dis. 23 (2000) 548-562
27. Zeman J., Pijackova A., Behulova J., Urge O., Saligova D., and Hyanek J. Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak Collaborative Study. Eur. J. Pediatr. 55 Suppl. 1 (1996) S56-S58
28. Albrecht J., Garbade S.F., and Burgard P. Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci. Biobehav. Rev. 33 (2009) 414-421
29. Walter J.H., White F.J., Hall S.K., MacDonald A., Rylance G., Boneh A., Francis D.E., Shortland G.J., Schmidt M., and Vail A. How practical are recommendations for dietary control in phenylketonuria?. Lancet 360 (2002) 55-57
30. Bosch A.M., Tybout W., van Spronsen F.J., de Valk H.W., Wijburg F.A., and Grootenhuis M.A. The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J. Inherit. Metab. Dis. 30 (2007) 29-34
31. Pietz J., Schmidt E., Matthis P., Kobialka B., Kutscha A., and de Sonneville L. EEGs in phenylketonuria. I. Follow-up to adulthood. II. Short-term diet-related changes in EEGs and cognitive function. Dev. Med. Child Neurol. 35 (1993) 54-64
32. Schmidt E., Rupp A., Burgard P., Pietz J., Weglage J., and de Sonneville L. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J. Clin. Exp. Neuropsychol. 16 (1994) 681-688
33. Pietz J., Fätkenheuer B., Burgard P., Armbruster M., Esser G., and Schmidt H. Psychiatric disorders in adult patients with early-treated phenylketonuria. J. Pediatr. 99 (1997) 345-350
34. Burgard P., Armbruster M., Schmidt E., and Rupp A. Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria. Acta Paediatr. Suppl. 407 (1994) 108-110
35. Coambs R.B., Jarry J.L., Jensen P., Her M.H., Porter J., Ferguson B.S., Abrahamsohn R.V., Mota V.L., Orechovsky V., and Pillai R. Prescription Noncompliance and Inappropriate Prescribing in Canada: Causes, Consequences, and Costs (1998), University of Toronto Press, Toronto
36. Garber J. Classification of childhood psychopathology: a developmental perspective. Child Dev. 55 (1984) 30-48
37. Lewis M., and Miller S.M. Handbook of Psychopathology (1990), Plenum Press, New York
38. Grootenhuis M.A., Stam H., Destree-Volk A., Heijmans H.S.A., and Last B.F. Levensloop Vragenlijst voor Jong-Volwassenen [Course of life questionnaire for young adults]. Gedrag Gezond. 31 (2002) 336-350
39. Weglage J., Fünders B., Ullrich K., Rupp A., and Schmidt E. Psychosocial aspects in phenylketonuria. Eur. J. Pediatr. 155 Suppl. 1 (1996) S101-S104
40. Ris M.D., Weber A.M., Hunt M.M., Berry H.K., Williams S.E., and Leslie N. Adult psychosocial outcome in early-treated phenylketonuria. J. Inherit. Metab. Dis. 20 (1997) 499-508